Differences in cellular signaling offer clues to insulin resistance
In what could be a starting point for new therapeutics to tackle insulin resistance, a major driver of type 2 diabetes and metabolic syndrome present in 20–30 percent of the general U.S. population, researchers recently ...
Sep 15, 2021
0
70